Correlation Between Tata Consultancy and Aarey Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tata Consultancy and Aarey Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tata Consultancy and Aarey Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tata Consultancy Services and Aarey Drugs Pharmaceuticals, you can compare the effects of market volatilities on Tata Consultancy and Aarey Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tata Consultancy with a short position of Aarey Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tata Consultancy and Aarey Drugs.

Diversification Opportunities for Tata Consultancy and Aarey Drugs

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Tata and Aarey is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Tata Consultancy Services and Aarey Drugs Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarey Drugs Pharmace and Tata Consultancy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tata Consultancy Services are associated (or correlated) with Aarey Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarey Drugs Pharmace has no effect on the direction of Tata Consultancy i.e., Tata Consultancy and Aarey Drugs go up and down completely randomly.

Pair Corralation between Tata Consultancy and Aarey Drugs

Assuming the 90 days trading horizon Tata Consultancy Services is expected to generate 0.53 times more return on investment than Aarey Drugs. However, Tata Consultancy Services is 1.88 times less risky than Aarey Drugs. It trades about -0.04 of its potential returns per unit of risk. Aarey Drugs Pharmaceuticals is currently generating about -0.07 per unit of risk. If you would invest  446,506  in Tata Consultancy Services on September 5, 2024 and sell it today you would lose (16,231) from holding Tata Consultancy Services or give up 3.64% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.41%
ValuesDaily Returns

Tata Consultancy Services  vs.  Aarey Drugs Pharmaceuticals

 Performance 
       Timeline  
Tata Consultancy Services 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tata Consultancy Services has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Tata Consultancy is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Aarey Drugs Pharmace 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarey Drugs Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Tata Consultancy and Aarey Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tata Consultancy and Aarey Drugs

The main advantage of trading using opposite Tata Consultancy and Aarey Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tata Consultancy position performs unexpectedly, Aarey Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarey Drugs will offset losses from the drop in Aarey Drugs' long position.
The idea behind Tata Consultancy Services and Aarey Drugs Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements